Opioids and restless legs syndrome: a double-edged sword.
作者信息
Winkelman John W
机构信息
Massachusetts General Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
出版信息
J Clin Sleep Med. 2023 Apr 1;19(4):641-642. doi: 10.5664/jcsm.10524.
Abstract
摘要
相似文献
1
Opioids and restless legs syndrome: a double-edged sword.
J Clin Sleep Med. 2023 Apr 1;19(4):641-642. doi: 10.5664/jcsm.10524.
2
Therapeutic Utility of Opioids for Restless Legs Syndrome.
Drugs. 2017 Aug;77(12):1337-1344. doi: 10.1007/s40265-017-0773-6.
3
[When L-Dopa preparations, dopamine agonists or opioids? Therapy of restless legs syndrome].
MMW Fortschr Med. 2003 Mar 6;145(10):48-9.
4
Latest guidelines and advances for treatment of restless legs syndrome.
J Clin Psychiatry. 2014 Apr;75(4):e08. doi: 10.4088/JCP.12074nr3c.
5
Restless leg syndrome. Stopping a sleep wrecker.
Mayo Clin Health Lett. 2010 May;28(5):6.
6
Calming restless legs.
Sleep. 2004 Aug 1;27(5):839-41.
7
French consensus: Treatment of newly diagnosed restless legs syndrome.
Rev Neurol (Paris). 2018 Sep-Oct;174(7-8):515-521. doi: 10.1016/j.neurol.2018.06.002. Epub 2018 Jul 24.
8
Opioid-induced hyperalgesia and dopamine-induced augmentation in an intractable and refractory case of RLS.
Sleep Med. 2015 Oct;16(10):1304. doi: 10.1016/j.sleep.2015.08.005. Epub 2015 Aug 18.
9
Restless legs syndrome, neuroleptic-induced akathisia, and the iron opioid dopamine link.
Sleep. 2024 Mar 11;47(3). doi: 10.1093/sleep/zsae008.
10
Restless legs syndrome: clinical presentation diagnosis and treatment.
Sleep Med. 2015 Jun;16(6):678-90. doi: 10.1016/j.sleep.2015.03.002. Epub 2015 Mar 10.
引用本文的文献
1
Restless legs syndrome, neuroleptic-induced akathisia, and opioid-withdrawal restlessness: shared neuronal mechanisms?
Sleep. 2024 Mar 11;47(3). doi: 10.1093/sleep/zsad273.
本文引用的文献
1
Long-term Safety, Dose Stability, and Efficacy of Opioids for Patients With Restless Legs Syndrome in the National RLS Opioid Registry.
Neurology. 2023 Apr 4;100(14):e1520-e1528. doi: 10.1212/WNL.0000000000206855. Epub 2023 Jan 25.
2
Emergence of restless legs syndrome during opioid discontinuation.
J Clin Sleep Med. 2023 Apr 1;19(4):741-748. doi: 10.5664/jcsm.10436.
3
Restless Legs Syndrome in X-linked adrenoleukodystrophy.
Sleep Med. 2022 Mar;91:31-34. doi: 10.1016/j.sleep.2022.02.008. Epub 2022 Feb 16.
4
Day-to-day opioid withdrawal symptoms, psychological distress, and opioid craving in patients with chronic pain prescribed opioid therapy.
Drug Alcohol Depend. 2021 Aug 1;225:108787. doi: 10.1016/j.drugalcdep.2021.108787. Epub 2021 May 29.
5
We need to do better: A systematic review and meta-analysis of diagnostic test accuracy of restless legs syndrome screening instruments.
Sleep Med Rev. 2021 Aug;58:101461. doi: 10.1016/j.smrv.2021.101461. Epub 2021 Mar 13.
6
Association between restless legs syndrome and peripheral neuropathy: A systematic review and meta-analysis.
Eur J Neurol. 2021 Jul;28(7):2423-2442. doi: 10.1111/ene.14840. Epub 2021 Apr 21.
7
Sex differences in factors predicting post-treatment opioid use.
Addiction. 2021 Aug;116(8):2116-2126. doi: 10.1111/add.15396. Epub 2021 Jan 22.
8
Successful discontinuation of oxycodone under pramipexole treatment for restless legs syndrome due to withdrawal.
Psychiatry Clin Neurosci. 2021 Mar;75(3):112-113. doi: 10.1111/pcn.13184. Epub 2020 Dec 22.
9
Baseline and 1-year longitudinal data from the National Restless Legs Syndrome Opioid Registry.
Sleep. 2021 Feb 12;44(2). doi: 10.1093/sleep/zsaa183.
10
Association of Restless Legs Syndrome With Risk of Suicide and Self-harm.
JAMA Netw Open. 2019 Aug 2;2(8):e199966. doi: 10.1001/jamanetworkopen.2019.9966.
Zotero 插件